Up Next
0
BioMarin's CEO On Its Product Pipeline
The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.
Share
BioMarin's CEO On Its Product Pipeline
The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.
Date: 1/8/13
Views: 218
Video by:  CNBC
 
Follow us:
Loading... 1 of 167
Today's Most Watched Videos
Related Videos
Loading... 1 of 56